PharmaBoardroom

Sanofi Korea – Kay Bae, General Manager

Sanofi’s Korean affiliate is the fifth largest recipient of clinical trial investments after the United States, France, Germany and the United…

KMDIA – Song In-Keum, Chairman – South Korea

Song In-Keum, chairman of the Korean Medical Devices Industry Association (KMDIA), discusses current opportunities offered by Korea’s growing…

Korea Institute of Toxicology – Lee Sang-Joon, President

The Korean Institute of Toxicology (KIT) is a government-funded research institute that evaluates the safety of medicine, bio-related products and…

CHA Health Systems – Han Joong Kim, Chairman, CHA Strategy…

Korea possesses enormous potential to become an exporter of futuristic health systems in the near future, and has already started the process. Kim…

KDRA– Kang-Choo Lee, President – South Korea

The Korea Drug Research Association (KDRA) was founded in 1986 to represent local pharmaceutical companies in their mission for global drug…

Astellas Korea – Jeong Hai-Do, President

The president of Astellas Korea offers his perspectives on Korea as a base for primary and clinical research, and the company's recent partnerships in…

P&K Skin Research Center – Kim Beom-Joon, Head Researcher…

The head researcher at P&K Skin Research Center discusses the potential of South Korea as a clinical trial hub, and the company's current…

MSD Korea – Don Hyun, President

Don Hyun, president of MSD Korea, shares his vision to bring Korean pharmaceutical companies to the global stage and to bring a locally produced drug…